175 related articles for article (PubMed ID: 32384510)
1. Risk of venous thromboembolism, use of enoxaparin and clinical outcomes in obese patients undergoing laparoscopic adjustable gastric band surgery: A retrospective study.
Hussain Z; Peterson GM; Mirkazemi C; Curtain C; Zaidi STR
Medicine (Baltimore); 2020 May; 99(19):e20174. PubMed ID: 32384510
[TBL] [Abstract][Full Text] [Related]
2. The EFFORT trial: Preoperative enoxaparin versus postoperative fondaparinux for thromboprophylaxis in bariatric surgical patients: a randomized double-blind pilot trial.
Steele KE; Canner J; Prokopowicz G; Verde F; Beselman A; Wyse R; Chen J; Streiff M; Magnuson T; Lidor A; Schweitzer M
Surg Obes Relat Dis; 2015; 11(3):672-83. PubMed ID: 25620436
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic Use of Enoxaparin in Adolescents During Bariatric Surgery-a Prospective Clinical Study.
Vaughns JD; Ziesenitz VC; Williams EF; Nadler EP; Mikus G; van den Anker J
Obes Surg; 2020 Jan; 30(1):63-68. PubMed ID: 31463801
[TBL] [Abstract][Full Text] [Related]
4. Use of Enoxaparin in Obese Adolescents During Bariatric Surgery--a Pilot Study.
Mushtaq A; Vaughns JD; Ziesenitz VC; Nadler EP; van den Anker JN
Obes Surg; 2015 Oct; 25(10):1869-74. PubMed ID: 25716128
[TBL] [Abstract][Full Text] [Related]
5. Thromboembolic events in bariatric surgery: a large multi-institutional referral center experience.
Jamal MH; Corcelles R; Shimizu H; Kroh M; Safdie FM; Rosenthal R; Brethauer SA; Schauer PR
Surg Endosc; 2015 Feb; 29(2):376-80. PubMed ID: 24986019
[TBL] [Abstract][Full Text] [Related]
6. Comparison of enoxaparin 40 mg versus 60 mg dosage for venous thromboprophylaxis in patients undergoing bariatric surgery: A randomized controlled trial.
Kongsawat K; Chaivanijchaya K; Pakul F; Joradol S; Kachornvitaya P; Boonchaya-Anant P; Udomsawaengsup S
Asian J Surg; 2024 Jul; 47(7):2985-2990. PubMed ID: 38514281
[TBL] [Abstract][Full Text] [Related]
7. Enoxaparin for thromboprophylaxis in morbidly obese patients undergoing bariatric surgery: findings of the prophylaxis against VTE outcomes in bariatric surgery patients receiving enoxaparin (PROBE) study.
Hamad GG; Choban PS
Obes Surg; 2005; 15(10):1368-74. PubMed ID: 16354513
[TBL] [Abstract][Full Text] [Related]
8. Implementation of an enoxaparin protocol for venous thromboembolism prophylaxis in obese surgical intensive care unit patients.
Ludwig KP; Simons HJ; Mone M; Barton RG; Kimball EJ
Ann Pharmacother; 2011 Nov; 45(11):1356-62. PubMed ID: 22009998
[TBL] [Abstract][Full Text] [Related]
9. Increasing Enoxaparin Dosing from 30 mg to 40 mg Does Not Affect Bleeding or VTE Risk in Bariatric Surgery Patients.
Taylor R; Madion M; Kleppe K; Mancini M; Mancini G; Hutson M; Yates J; Daigle H
Am Surg; 2024 Jun; 90(6):1784-1786. PubMed ID: 38531833
[No Abstract] [Full Text] [Related]
10. The effect of extended post-discharge chemical thromboprophylaxis on venous thromboembolism rates after bariatric surgery: a prospective comparison trial.
Raftopoulos I; Martindale C; Cronin A; Steinberg J
Surg Endosc; 2008 Nov; 22(11):2384-91. PubMed ID: 18622558
[TBL] [Abstract][Full Text] [Related]
11. Laparoscopic adjustable gastric band removal and outcome of subsequent revisional bariatric procedures: A retrospective review of 214 consecutive patients.
Kirshtein B; Kirshtein A; Perry Z; Ovnat A; Lantsberg L; Avinoach E; Mizrahi S
Int J Surg; 2016 Mar; 27():133-137. PubMed ID: 26808324
[TBL] [Abstract][Full Text] [Related]
12. Reasons and outcomes of laparoscopic revisional surgery after laparoscopic adjustable gastric banding for morbid obesity.
Patel S; Eckstein J; Acholonu E; Abu-Jaish W; Szomstein S; Rosenthal RJ
Surg Obes Relat Dis; 2010; 6(4):391-8. PubMed ID: 20655021
[TBL] [Abstract][Full Text] [Related]
13. Increased bleeding risk with enoxaparin venothromboembolism prophylaxis compared with heparin in patients undergoing bariatric surgery.
Reiter AJ; Prinz J; Li Y; Nagle AP; Hungness ES; Teitelbaum EN
Surg Endosc; 2023 Sep; 37(9):6983-6988. PubMed ID: 37344753
[TBL] [Abstract][Full Text] [Related]
14. Comparison of two low-molecular-weight heparin dosing regimens for patients undergoing laparoscopic bariatric surgery.
Simone EP; Madan AK; Tichansky DS; Kuhl DA; Lee MD
Surg Endosc; 2008 Nov; 22(11):2392-5. PubMed ID: 18594915
[TBL] [Abstract][Full Text] [Related]
15. Adding a Preoperative Dose of LMWH may Decrease VTE Following Bariatric Surgery.
Abdelsalam AM; ElAnsary AMSE; Salman MA; Nassef SA; Elfergany HM; Aisha HAA
World J Surg; 2021 Jan; 45(1):126-131. PubMed ID: 32989579
[TBL] [Abstract][Full Text] [Related]
16. Risk factors for postdischarge venous thromboembolism among bariatric surgery patients and the evolving approach to extended thromboprophylaxis with enoxaparin.
O'Connor K; Garcia Whitlock AE; Tewksbury C; Williams NN; Dumon KR
Surg Obes Relat Dis; 2021 Jun; 17(6):1218-1225. PubMed ID: 33814315
[TBL] [Abstract][Full Text] [Related]
17. Revisional surgery after failed laparoscopic adjustable gastric banding.
Tucker O; Sucandy I; Szomstein S; Rosenthal RJ
Surg Obes Relat Dis; 2008; 4(6):740-7. PubMed ID: 18539539
[TBL] [Abstract][Full Text] [Related]
18. Retrospective Evaluation of Postoperative Adverse Drug Events in Patients Receiving Rivaroxaban After Major Orthopedic Surgery Compared with Standard Therapy in a Community Hospital.
Cieri NE; Kusmierski K; Lackie C; Van Opdorp A; Hassan AK
Pharmacotherapy; 2017 Feb; 37(2):170-176. PubMed ID: 28028830
[TBL] [Abstract][Full Text] [Related]
19. Enoxaparin thromboprophylaxis in gastric bypass patients: extended duration, dose stratification, and antifactor Xa activity.
Borkgren-Okonek MJ; Hart RW; Pantano JE; Rantis PC; Guske PJ; Kane JM; Gordon N; Sambol NC
Surg Obes Relat Dis; 2008; 4(5):625-31. PubMed ID: 18261965
[TBL] [Abstract][Full Text] [Related]
20. Extended thromboprophylaxis reduces incidence of postoperative venous thromboembolism in laparoscopic bariatric surgery.
Magee CJ; Barry J; Javed S; Macadam R; Kerrigan D
Surg Obes Relat Dis; 2010; 6(3):322-5. PubMed ID: 20510295
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
